LAS VEGAS – Evolocumab, an investigational antibody that inhibits PCSK9, reduces levels of low-density lipoprotein cholesterol in hypercholesterolemic patients who have dysglycemia or metabolic...
WASHINGTON – Treating acute venous thromboembolism with the fixed-dose oral factor Xa inhibitor apixaban significantly reduces subsequent all-cause hospitalizations, compared with conventional...
Physician leaders are voicing support for a proposed federal law that aims to reduce litigation against doctors, lower health care costs, and establish more fairness in the analyzing of malpractice...
The rate of diabetes-related myocardial infarction has fallen almost 68% since 1990, according to an analysis of several federal data sources.
From 1990 to 2010, the rate of acute MI among adults...
WASHINGTON – Being married is independently associated with a significantly reduced rate of vascular disease across all arterial beds, according to a population-based study of more than 3.5 million...
WASHINGTON– Low HDL cholesterol does not increase the risk of coronary heart disease when LDL cholesterol and triglyceride levels are normal, according to an analysis from the <link...
WASHINGTON – Marital status plays an underappreciated role in heart failure prognosis.
Indeed, having a life partner was independently associated with a 12% reduction in the risk of all-cause...
WASHINGTON – Continuous cardiac monitoring via Medtronic’s insertable REVEAL XT device resulted in detection of atrial fibrillation in 30% of cryptogenic stroke patients at 36 months of follow-up in...
Results of TOPCAT, one of the most talked about heart failure trials in recent years, have been published. There were no obvious surprises: Spironolactone is no more beneficial than placebo for...